{
    "body": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23095891", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22974708", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17584081", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22488849", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21562564", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20823234", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19289631", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9207788", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21196490", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9585603", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22210878", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20087400", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11180599", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22156581", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12497640", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22891273", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15712272", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23359070", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18775957", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16773578"
    ], 
    "ideal_answer": [
        "So far, mutations in Notch and other components of its signaling pathway have been implicated in an array of human diseases (T-cell leukemia and other cancers,  Multiple Sclerosis,  CADASIL,  Alagille Syndrome,  Spondylocostal Dysostosis), but more pathologies are likely to be associated with Notch in the future due to its network complexity."
    ], 
    "exact_answer": [
        [
            "Alagille syndrome"
        ], 
        [
            "spondylocostal dysostosis"
        ], 
        [
            "CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)"
        ], 
        [
            "T-cell acute lymphoblastic leukemia"
        ]
    ], 
    "type": "list", 
    "id": "5173eb428ed59a060a000021", 
    "snippets": [
        {
            "offsetInBeginSection": 954, 
            "offsetInEndSection": 1073, 
            "text": "Comparative functional genomic analysis identified a signature of Notch activation in 30% of HCC samples from patients.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22974708", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 450, 
            "offsetInEndSection": 705, 
            "text": "Here, we performed whole transcriptome sequencing on a discovery cohort of 18 primary tissue MCL samples and 2 cell lines. We found recurrent mutations in NOTCH1, a finding that we confirmed in an extension cohort of 108 clinical samples and 8 cell lines.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22210878", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 466, 
            "offsetInEndSection": 714, 
            "text": "We found activating mutations in Notch in more than 30% of ATL patients. These activating mutations are phenotypically different from those previously reported in T-ALL leukemias and may represent polymorphisms for activated Notch in human cancers.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20823234", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1302, 
            "offsetInEndSection": 1429, 
            "text": "We detected Notch1 missense mutations in 8.3% of the tumors (only in the posterior fossa location and in case of 9q33-34 gain).", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19289631", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 114, 
            "offsetInEndSection": 360, 
            "text": "Importantly, mutations of the Notch protein and components of its signaling pathway have been implicated in an array of human diseases (T-cell leukemia and other cancers, Multiple Sclerosis, CADASIL, Alagille Syndrome, Spondylocostal Dysostosis).", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17584081", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 606, 
            "offsetInEndSection": 786, 
            "text": "Here, we demonstrate that endothelial-specific deletion of Jag1 leads to cardiovascular defects in both embryonic and adult mice that are reminiscent of those in Alagille syndrome.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23095891", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 270, 
            "offsetInEndSection": 493, 
            "text": "In this study, analysis of 21 Vietnamese ALGS individuals led to the identification of 19 different mutations (18 JAG1 and 1 NOTCH2), 17 of which are novel, including the third reported NOTCH2 mutation in Alagille Syndrome.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22488849", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 393, 
            "text": "Genetics of Holoprosencephaly (HPE), a congenital malformation of the developing human forebrain, is due to multiple genetic defects. Most genes that have been implicated in HPE belong to the sonic hedgehog signaling pathway. Here we describe a new candidate gene isolated from array comparative genomic hybridization redundant 6qter deletions, DELTA Like 1 (DLL1), which is a ligand of NOTCH.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21196490", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 344, 
            "offsetInEndSection": 839, 
            "text": "Four genes causing a subset of autosomal recessive forms of this disease have been identified: DLL3 (SCDO1: MIM 277300), MESP2 (SCDO2: MIM 608681), LFNG (SCDO3: MIM609813) and HES7 (SCDO4). These genes are all essential components of the Notch signalling pathway, which has multiple roles in development and disease. Previously, only a single SCD-causative missense mutation was described in HES7. In this study, we have identified two new missense mutations in the HES7 gene in a single family,", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20087400", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 647, 
            "offsetInEndSection": 816, 
            "text": "Here we have used autozygosity mapping to identify a mutation in a fourth Notch pathway gene, Hairy-and-Enhancer-of-Split-7 (HES7), in an autosomal recessive SCD family.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18775957", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 432, 
            "text": "Alagille syndrome (AGS) is caused by mutations in the gene for the Notch signaling pathway ligand Jagged1 (JAG1), which are found in 94% of patients. To identify the cause of disease in patients without JAG1 mutations, we screened 11 JAG1 mutation-negative probands with AGS for alterations in the gene for the Notch2 receptor (NOTCH2). We found NOTCH2 mutations segregating in two families and identified five affected individuals.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16773578", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 139, 
            "offsetInEndSection": 381, 
            "text": "Mutations in the JAG1 (Jagged 1) gene, coding a ligand in the evolutionarily conserved Notch signaling pathway, are responsible for AGS. Here we present sixteen different JAG1 gene mutations, among them twelve novel, not described previously.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15712272", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1050, 
            "offsetInEndSection": 1168, 
            "text": "Altogether 226 different JAG1 mutations have been described in association with AGS, including our novel 36 mutations.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/12497640", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 163, 
            "offsetInEndSection": 603, 
            "text": "Previous studies have demonstrated that a wide spectrum of JAG1 mutations result in AGS. These include total gene deletions, protein truncating, splicing and missense mutations which are distributed across the coding region of the gene. Here we present results of JAG1 mutation screening by SSCP and FISH in 105 patients with AGS. For these studies, new primers were designed for 12 exons. Mutations were identified in 63/105 patients (60%)", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/11180599", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 445, 
            "offsetInEndSection": 916, 
            "text": "We have screened 54 AGS probands and family members to determine the frequency of mutations in JAG1. Three patients (6%) had deletions of the entire gene. Of the remaining 51 patients, 35 (69%) had mutations within JAG1, identified by SSCP analysis. Of the 35 identified intragenic mutations, all were unique, with the exceptions of a 5-bp deletion in exon 16, seen in two unrelated patients, and a C insertion at base 1618 in exon 9, also seen in two unrelated patients.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9585603", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 157, 
            "offsetInEndSection": 534, 
            "text": "Analyses of many patients with cytogenetic deletions or rearrangements have mapped the gene to chromosome 20p12, although deletions are found in a relatively small proportion of patients (< 7%). We have mapped the human Jagged1 gene (JAG1), encoding a ligand for the developmentally important Notch transmembrane receptor, to the Alagille syndrome critical region within 20p12.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9207788", 
            "endSection": "sections.0"
        }
    ]
}